Please use this identifier to cite or link to this item:
|Type:||Artigo de periódico|
|Title:||Smad5 regulates Akt2 expression and insulin-induced glucose uptake in L6 myotubes|
|Author:||ANHE, Fernando F.|
LEITE, Adriana R.
HIRABARA, Sandro M.
BOSCHERO, Antonio C.
ANHE, Gabriel F.
|Abstract:||Insulin-induced glucose uptake by skeletal muscle results from Akt2 activation and is severely impaired during insulin resistance Recently, we and others have demonstrated that BMP9 improves glucose homeostasis in diabetic and non-diabetic rodents. However, the mechanism by which BMP9 modulates insulin action remains unknown. Here we demonstrate that Smad5. a transcription factor activated by BMP9, and Akt2. are upregulated in differentiated L6 myotubes. Smad5, rather than Smad1/8, is downregulated ""in vivo"" and ""in vitro"" by dexamethasone Smad5 knockdown decreased Akt2 expression and serine phosphorylation and insulin-induced glucose uptake, and increased the expression of the lipid phosphatase Ship2. Additionally, binding of Smad5 to Akt2 gene is decreased in dexamethasone-treated rats and Increased in L6 myotubes compared to myoblasts The present study indicates that Smad5 regulates glucose uptake in skeletal muscle by controlling Akt2 expression and phosphorylation These finding reveals Smad5 as a potential target for the therapeutic of type 2 diabetes. (C) 2010 Elsevier Ireland Ltd. All rights reserved.|
|Editor:||ELSEVIER IRELAND LTD|
|Citation:||MOLECULAR AND CELLULAR ENDOCRINOLOGY, v.319, n.1/Fev, p.30-38, 2010|
|Appears in Collections:||IB - Artigos e Outros Documentos|
Files in This Item:
|art_ANHE_Smad5_regulates_Akt2_expression_and_insulin-induced_glucose_2010.pdf||published version||795.2 kB||Adobe PDF||View/Open|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.